| Year |
Citation |
Score |
| 2011 |
Cho S, Lu M, He X, Ee PL, Bhat U, Schneider E, Miele L, Beck WT. Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 108: 20778-83. PMID 22143792 DOI: 10.1073/Pnas.1019452108 |
0.444 |
|
| 2007 |
Yao R, Schneider E. Detection of B- and T-cell-specific gene rearrangements in 13 cell lines and 50 clinical specimens using the BIOMED-2 and the original InVivoScribe primers. Leukemia & Lymphoma. 48: 837-40. PMID 17454651 DOI: 10.1080/10428190601187729 |
0.334 |
|
| 2006 |
Schneider E, Ryan TJ. Gamma-glutamyl hydrolase and drug resistance. Clinica Chimica Acta; International Journal of Clinical Chemistry. 374: 25-32. PMID 16859665 DOI: 10.1016/J.Cca.2006.05.044 |
0.412 |
|
| 2005 |
Marshall LA, Rhee MS, Hofmann L, Khodjakov A, Schneider E. Increased lysosomal uptake of methotrexate-polyglutamates in two methotrexate-resistant cell lines with distinct mechanisms of resistance. Biochemical Pharmacology. 71: 203-13. PMID 16263093 DOI: 10.1016/j.bcp.2005.10.008 |
0.49 |
|
| 2005 |
Rhee MS, Schneider E. Lack of an effect of breast cancer resistance protein (BCRP/ABCG2) overexpression on methotrexate polyglutamate export and folate accumulation in a human breast cancer cell line. Biochemical Pharmacology. 69: 123-32. PMID 15588721 DOI: 10.1016/j.bcp.2004.09.007 |
0.563 |
|
| 2004 |
Kowalski P, Farley KM, Lage H, Schneider E. Effective knock down of very high ABCG2 expression by a hammerhead ribozyme Anticancer Research. 24: 2231-2235. PMID 15330166 |
0.428 |
|
| 2003 |
Volk EL, Pankuch JJ, Chave KJ, Coward JK, Schneider E. A rapid assay for the quantitation of gamma-glutamyl hydrolase using a fluorogenic peptide as substrate. Biotechniques. 35: 926-8, 930, 932. PMID 14628664 DOI: 10.2144/03355Bm04 |
0.679 |
|
| 2003 |
Volk EL, Schneider E. Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter. Cancer Research. 63: 5538-43. PMID 14500392 |
0.772 |
|
| 2002 |
Volk EL, Farley KM, Wu Y, Li F, Robey RW, Schneider E. Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance. Cancer Research. 62: 5035-40. PMID 12208758 |
0.792 |
|
| 2002 |
Yao R, Rich SA, Schneider E. Validation of sixteen leukemia and lymphoma cell lines as controls for molecular gene rearrangement assays. Clinical Chemistry. 48: 1344-51. PMID 12142393 DOI: 10.1093/Clinchem/48.8.1344 |
0.335 |
|
| 2001 |
Diah SK, Smitherman PK, Aldridge J, Volk EL, Schneider E, Townsend AJ, Morrow CS. Resistance to mitoxantrone in multidrug-resistant MCF7 breast cancer cells: evaluation of mitoxantrone transport and the role of multidrug resistance protein family proteins. Cancer Research. 61: 5461-7. PMID 11454692 |
0.794 |
|
| 2000 |
Pirnia F, Breuleux M, Schneider E, Hochmeister M, Bates SE, Marti A, Hotz MA, Betticher DC, Borner MM. Uncertain Identity of Doxorubicin-Resistant MCF-7 Cell Lines Expressing Mutated p53 Journal of the National Cancer Institute. 92: 1535-1536. PMID 10995814 DOI: 10.1093/Jnci/92.18.1535 |
0.481 |
|
| 2000 |
Yang CH, Schneider E, Kuo ML, Volk EL, Rocchi E, Chen YC. BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells. Biochemical Pharmacology. 60: 831-7. PMID 10930538 DOI: 10.1016/S0006-2952(00)00396-8 |
0.785 |
|
| 2000 |
Volk EL, Rohde K, Rhee M, McGuire JJ, Doyle LA, Ross DD, Schneider E. Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux. Cancer Research. 60: 3514-21. PMID 10910063 |
0.792 |
|
| 2000 |
Rocchi E, Khodjakov A, Volk EL, Yang CH, Litman T, Bates SE, Schneider E. The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane. Biochemical and Biophysical Research Communications. 271: 42-6. PMID 10777678 DOI: 10.1006/Bbrc.2000.2590 |
0.755 |
|
| 2000 |
Knutsen T, Rao VK, Ried T, Mickley L, Schneider E, Miyake K, Ghadimi BM, Padilla-Nash H, Pack S, Greenberger L, Cowan K, Dean M, Fojo T, Bates S. Amplification of 4q21-q22 and the MXR gene in independently derived mitoxantrone-resistant cell lines. Genes, Chromosomes & Cancer. 27: 110-6. PMID 10564593 DOI: 10.1002/(Sici)1098-2264(200001)27:1<110::Aid-Gcc14>3.0.Co;2-4 |
0.339 |
|
| 1999 |
Ross DD, Yang W, Abruzzo LV, Dalton WS, Schneider E, Lage H, Dietel M, Greenberger L, Cole SP, Doyle LA. Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. Journal of the National Cancer Institute. 91: 429-33. PMID 10070941 DOI: 10.1093/Jnci/91.5.429 |
0.602 |
|
| 1998 |
Morrow CS, Smitherman PK, Diah SK, Schneider E, Townsend AJ. Coordinated action of glutathione S-transferases (GSTs) and multidrug resistance protein 1 (MRP1) in antineoplastic drug detoxification. Mechanism of GST A1-1- and MRP1-associated resistance to chlorambucil in MCF7 breast carcinoma cells Journal of Biological Chemistry. 273: 20114-20120. PMID 9685354 DOI: 10.1074/jbc.273.32.20114 |
0.455 |
|
| 1998 |
Morrow CS, Diah S, Smitherman PK, Schneider E, Townsend AJ. Multidrug resistance protein and glutathione S-transferase P1-1 act in synergy to confer protection from 4-nitroquinoline 1-oxide toxicity Carcinogenesis. 19: 109-115. PMID 9472701 DOI: 10.1093/carcin/19.1.109 |
0.433 |
|
| 1997 |
Wyler B, Shao Y, Schneider E, Cianfriglia M, Scheper RJ, Frey BM, Gieseler F, Schmid L, Twentyman PR, Lehnert M. Intermittent exposure to doxorubicin in vitro selects for multifactorial non-P-glycoprotein-associated multidrug resistance in RPMI 8226 human myeloma cells. British Journal of Haematology. 97: 65-75. PMID 9136943 DOI: 10.1046/j.1365-2141.1997.52649.x |
0.492 |
|
| 1997 |
Takatani H, Oka M, Fukuda M, Narasaki F, Nakano R, Ikeda K, Terashi K, Kinoshita A, Soda H, Kanda T, Schneider E, Kohno S. Gene mutation analysis and quantitation of DNA topoisomerase I in previously untreated non-small cell lung carcinomas Japanese Journal of Cancer Research. 88: 160-165. PMID 9119744 DOI: 10.1111/J.1349-7006.1997.Tb00361.X |
0.388 |
|
| 1997 |
Perez-Soler R, Neamati N, Zou Y, Schneider E, Doyle LA, Andreeff M, Priebe W, Ling YH. Annamycin circumvents resistance mediated by the multidrug resistance-associated protein (MRP) in breast MCF-7 and small-cell lung UMCC-1 cancer cell lines selected for resistance to etoposide. International Journal of Cancer. 71: 35-41. PMID 9096663 DOI: 10.1002/(Sici)1097-0215(19970328)71:1<35::Aid-Ijc8>3.0.Co;2-4 |
0.614 |
|
| 1995 |
Sinha BK, Yamazaki H, Eliot HM, Schneider E, Borner MM, O'Connor PM. Relationships between proto-oncogene expression and apoptosis induced by anticancer drugs in human prostate tumor cells. Biochimica Et Biophysica Acta. 1270: 12-8. PMID 7827130 DOI: 10.1016/0925-4439(94)00065-X |
0.481 |
|
| 1995 |
Sokolova IA, Cowan KH, Schneider E. Ca2+/Mg(2+)-dependent endonuclease activation is an early event in VP-16-induced apoptosis of human breast cancer MCF7 cells in vitro. Biochimica Et Biophysica Acta. 1266: 135-42. PMID 7742378 DOI: 10.1016/0167-4889(94)00233-5 |
0.305 |
|
| 1995 |
Schneider E, Cowan K, Bader H, Toomey S, Schwartz G, Karp J, Burke P, Kaufmann S. Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia Blood. 85: 186-193. DOI: 10.1182/Blood.V85.1.186.Bloodjournal851186 |
0.401 |
|
| 1995 |
Goldsmith ME, Gudas JM, Schneider E, Cowan KH. Wild Type p53 Stimulates Expression from the Human Multidrug Resistance Promoter in a p53-negative Cell Line Journal of Biological Chemistry. 270: 1894-1898. DOI: 10.1074/Jbc.270.4.1894 |
0.401 |
|
| 1994 |
Yamazaki H, Schneider E, Myers CE, Sinha BK. Oncogene overexpression and de novo drug-resistance in human prostate cancer cells Bba - Molecular Basis of Disease. 1226: 89-96. PMID 8155744 DOI: 10.1016/0925-4439(94)90063-9 |
0.51 |
|
| 1994 |
Borner MM, Schneider E, Pirnia F, Sartor O, Trepel JB, Myers CE. The detergent Triton X-100 induces a death pattern in human carcinoma cell lines that resembles cytotoxic lymphocyte-induced apoptosis. Febs Letters. 353: 129-32. PMID 7926036 DOI: 10.1016/0014-5793(94)01023-4 |
0.328 |
|
| 1994 |
Schneider E, Cowan KH. Multiple drug resistance in cancer therapy Medical Journal of Australia. 160: 371-373. DOI: 10.5694/J.1326-5377.1994.Tb138241.X |
0.426 |
|
| 1994 |
Kaufmann S, Karp J, Jones R, Miller C, Schneider E, Zwelling L, Cowan K, Wendel K, Burke P. Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia Blood. 83: 517-530. DOI: 10.1182/Blood.V83.2.517.517 |
0.35 |
|
| Show low-probability matches. |